Ramírez-López G, González-Villalpando C, Salmerón J, González-Ortiz M, Valles-Sánchez V

Idioma: Ingles.
Referencias bibliográficas: 37
Paginas: 293-299
Archivo PDF: 104.75 Kb.

RESUMEN

Objetivo. Evaluar la relación entre lípidos e insulina en adolescentes. Material y métodos. Estudio transversal en 350 adolescentes de 14 a 19 años de preparatoria pública en Guadalajara, Jal., México. La insulina se midió por inmunoensayo enzimático de micropartícula, el colesterol total y triglicéridos por pruebas enzimáticas estándares, y las lipoproteínas de baja y alta densidad por métodos de precipitación. Se utilizó análisis de regresión lineal multivariada. Resultados. Los triglicéridos se asociaron en forma positiva con insulina (β= 0.003, p= 0.0001) y la lipoproteína de alta densidad se asoció en forma negativa con insulina en varones de 18-19 años de edad (β= -0.03, p= 0.012). Conclusiones. En los adolescentes, los triglicéridos y las lipoproteínas de alta densidad están asociados con la insulinemia.

REFERENCIAS (EN ESTE ARTÍCULO)

1. Instituto Nacional de Estadística, Geografía e Informática/Secretaría de Salud. Dirección General de Información General en Salud. Base de datos de defunciones 2002. México: INEGI, 2004.

2. Berenson G, Radhakrishnamurthy B, Bao W, Srinivasan S. Does adult-onset diabetes mellitus begin in childhood?: The Bogalusa Heart Study. Am J Med Sci 1995;310:Suppl 1:S77-S82.

3. Zimmet P, Collins V, Dowse G, Knight LT. Hyperinsulinemia in youth is a predictor of type 2 (non-insulin-dependent) diabetes. Diabetologia 1993;35:534-541.

4. Burke JP, Williams K, Haffner SM, González-Villalpando C, Stern MP. Elevated incidence of type 2 diabetes in San Antonio, Texas, compared with that of Mexico City, Mexico. Diabetes Care 2001;24:1573-1578.

5. Alberti G, Zimmet P, Shaw J, Bloomgarden Z, Kaufman F, Silinik M. Type 2 diabetes in the young: the evolving epidemic. The Intenational Diabetes Federation Consensus Workshop. Diabetes Care 2004;27(7):1798-1811.

6. Duncan Glen E, Li Sierra M, Zhuo Xiao-Hua. Prevalence and trends of a metabolic syndrome phenotype among U.S. Adolescents, 1999-2000. Diabetes Care 2004;27(10):2438-2443.

7. DeFronzo R, Ferrannini E. Insulin resistance. A multifaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia, and atherosclerotic cardiovascular disease. Diabetes Care 1991;14:173-194.

8. Pouliot MC, Després JP, Lemieux S, Moorjani S, Bouchard C, Tremblay A, et al. Waist circumference and abdominal sagittal diameter: best simple anthropometric indexes of abdominal visceral adipose tissue accumulation and related cardiovascular risk in men and women. Am J Cardiol 1994;73:460-468.

9. Olfesky J, Nolan J. Insulin resistance and non-insulin-dependent diabetes mellitus: cellular and molecular mechanisms. Am J Clin Nutr 1995;61 Suppl:980S-986S.

10. Cigolini M, Seidell JC, Targher G, Deslypere JP, Ellsinger BM, Charzewska J, et al. Fasting serum insulin in relation to components of metabolic syndrome in European healthy men: The European Fat Distribution Study. Metabolism 1995;44:35-40.

11. Karhapaa P, Malkki M, Laakso M. Isolated low HDL cholesterol. An insulin-resistant state. Diabetes 1994;43:411-417.

12. Garg A. Insulin resistance in the pathogenesis of dyslipidemia. Diabetes Care 1996;19:387-389.

13. Sinaiko AR, Donahue RP, Jacobs DR Jr, Prineas RJ. Relation of weight and rate of increase in weight during childhood and adolescence to body size, blood pressure, fasting insulin, and lipids in young adults. The Minneapolis Children’s Blood Pressure Study. Circulation 1999;99:1471-1476.

14. Arslanian S, Kalhna S. Correlation between fatty acid and glucose metabolism. Potential explanation of insulin resistance of puberty. Diabetes 1994;43:908-914.

15. Bonora E, Targher G, Zenere MB, Saggiani F, Cacciatori V, Tosi F, et al. Relationship between fasting insulin and cardiovascular risk factors is already present in young men: the Verona Young Men Atherosclerosis Risk Factors Study. Eur J Clin Invest 1997;27:248-254.

16. Steinberger J, Moorehead C, Katch V, Rocchini AP. Relationship between insulin resistance and abnormal lipid profile in obese adolescents. J Pediatr 1995;126:690-695.

17. Moussa M, Shaltout AA, Nkansa-Dwamena D, Mourad M, Al-Sheikh N, Agha N, et al. Association of fasting insulin with serum lipids and blood pressure in Kuwaiti children. Metabolism 1998;47:420-424.

18. Chu N, Rimm E, Wang D, Liou H, Shieh S. Relationship between anthropometric variables and lipid levels among school children: The Taipei Children Heart Study. Int J Obes Relat Metab Disord 1998;22:66-72.

19. Freedman D, Serdula M, Srinivasan S, Berenson G. Relation of circumferences and skinfold thicknesses to lipid and insulin concentrations in children and adolescents: the Bogalusa Heart Study. Am J Clin Nutr 1999;69:308-317.

20. Ramírez-López G, González-Villalpando C, Sánchez-Corona J, Salmerón-Castro J, González-Ortiz M, Celis-de la Rosa A, et al. Weight, physical activity, and smoking as determinants of insulinemia in adolescents. Arch Med Res 2001;32:208-213.

21. Tietz N. Clinical guide to laboratory tests. 2nd ed. Philadelphia: WB Saunders, 1990.

22. Siedel J, Hagele E, Ziegenhorn J, Wahlefeld A. Reagent for the enzymatic determination of serum total cholesterol with improved lipolytic efficiency. Clin Chem 1983;29:1075-1080.

23. Bergmeyer H. Methoden enzimatischen analyse. 3rd ed. Wenheim: Verlag Chemic, 1974.

24. Greten H, Lang P, Schettler G. Lipoproteine und Herzinfarkt. Baden-Baden: Witzstrock-Verlag, 1979.

25. Burstein M, Scholnick H, Morfin R. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions. J Lipid Res 1970;11:583-595.

26. Lohman T, Roche A, Martorell R. Anthropometric Standardization Reference Manual. Champaign IL: Human Kinetics Books, 1988.

27. Casillas L, Vargas L. La distribución de grasa corporal, posible factor de riesgo para la salud. Cuadernos de Nutrición 1993;16:7-15.

28. Sallis J, Buono M, Roby J, Micale F, Nelson J. Seven-day recall and other physical activity self-reports in children and adolescents. Med Sci Sports Exerc 1993;25:99-108.

29. Ainsworth BE, Haskell WL, Leon AS, Jacobs DR Jr, Montoye HJ, Sallis JF, et al. Compendium of physical activities: classification of energy costs of human physical activities. Med Sci Sports Exerc 1993;25:71-80.

30. Hernández-Avila M, Romieu I, Parra S, Hernández-Avila J, Madrigal H, Willet W. Validity and reproducibility of a food frequency questionnaire to assess dietary intake of women living in Mexico City. Salud Publica Mex 1998;40:133-140.

31. Instituto Nacional de Salud Pública. Snut Sistema de Evaluación de Hábitos Nutricionales y Consumo de Nutrimentos. Cuernavaca Mor., México: INSP, 2003.

32. Grupo de Estudio de Insulinemia en Adolescentes. Concentración de insulina y lípidos séricos en adolescentes de preparatoria en Guadalajara, México. Salud Publica Mex 2003;45:S103-S107.

33. Jiang X, Srinivasan S, Webber L, Wattigney W, Berenson G. Association of fasting insulin level with serum lipid and lipoprotein levels in children, adolescents, and young adults: The Bogalusa Heart Study. Arch Intern Med 1995;155(2):190-196.

34. Porkka KVK, Viikari JSA, Rönnemaa T, Marniemi J, Åkerblom HK. Age and gender specific serum lipid and apolipoprotein fractiles of Finnish children and young adults. The Cardiovascular Risk in Young Finns Study. Acta Pædiatr 1994;83:838-848.

35. Webber LS, Srinivasan SR, Wattigney WA, Berenson GS. Tracking of serum lipids and lipoproteins from childhood to adulthood. The Bogalusa Heart Study. Am J Epidemiol 1991;133:884-899.

36. Randle P, Garland P, Hales C, Newsholme E. The glucose fatty-acid cycle. Its role in insulin sensitivity and the metabolic disturbances of diabetes mellitus. Lancet 1963;I:785-789.

37. Hennes M, Shrago E, Kissebah A. Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics. Int J Obes 1990;14:829-830.